“Defendants ignored their duties and responsibility to protect against oversupply and diversion of opioids for illicit and nonmedical uses.
ADBefore that trial began, Oklahoma also settled with manufacturers Purdue and Teva Pharmaceuticals for a total of $355 million.
Last week, the state reached an $8.75 million settlement with another drug manufacturer, Endo Pharmaceuticals.
Now the state has turned to the three wholesalers, which control 85 percent of the drug distribution market in the United States.
ADIn its lawsuit, Oklahoma claims the three companies violated a similar state law and their “common law duty to exercise reasonable care in delivering dangerous narcotic substances” by failing to take those actions.